Does Rallies show Form 4 insider transactions for PHVS?

Yes. Rallies tracks PHVS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is PHVS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PHVS. It does not provide personalized investment advice.

PHVS (Pharvaris N.V. Ordinary Shares) Stock Analysis - Insider Trades

Pharvaris N.V. Ordinary Shares (PHVS) is a publicly traded Healthcare sector company. As of May 21, 2026, PHVS trades at $29.45 with a market cap of $2.01B and a P/E ratio of 0.00. PHVS moved +1.66% today. Year to date, PHVS is +18.37%; over the trailing twelve months it is +70.72%. Its 52-week range spans $11.51 to $33.33. Analyst consensus is strong buy with an average price target of $49.10. Rallies surfaces PHVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading PHVS stock inside the company?

Recent PHVS insider activity includes Modig Berndt sold 2.29K, Glassman Robert sold 5.33K, Glassman Robert sold 4.67K, Abele Stefan Andreas sold 8.75K, and Souverijns Wim sold 10.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

PHVS Key Metrics

Key financial metrics for PHVS
Metric	Value
Price	$29.45
Market Cap	$2.01B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$33.33
52-Week Low	$11.51
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Recent PHVS Insider Trades

Modig Berndt sold 2.29K (~$66.98K) on May 18, 2026.
Glassman Robert sold 5.33K (~$159.09K) on May 15, 2026.
Glassman Robert sold 4.67K (~$139.15K) on May 15, 2026.
Abele Stefan Andreas sold 8.75K (~$260.86K) on May 15, 2026.
Souverijns Wim sold 10.00K (~$299.16K) on May 15, 2026.

Latest PHVS News

Pharvaris Sees $74 Analyst Target, $132.3M Raise and 2026 HAE Data — May 13, 2026
Pharvaris Extends Cash Runway to 2028 with €247M and $132M Raise — May 12, 2026
Pharvaris Raises $132.3 Million in Upsized 4.5 Million-Share Offering — May 11, 2026
Pharvaris Prices $115 Million Equity Offering at $29.68 per Share — May 8, 2026
Pharvaris Holds €292M Cash, On Track for 1H2026 NDA and Q3 2026 Data — Apr 2, 2026

PHVS Analyst Consensus

10 analysts cover PHVS: 0 strong buy, 9 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $49.10.

Common questions about PHVS

Who is trading PHVS stock inside the company?: Recent PHVS insider activity includes Modig Berndt sold 2.29K, Glassman Robert sold 5.33K, Glassman Robert sold 4.67K, Abele Stefan Andreas sold 8.75K, and Souverijns Wim sold 10.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for PHVS?: Yes. Rallies tracks PHVS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PHVS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PHVS. It does not provide personalized investment advice.